Arrayit (OTCMKTS:ARYC – Get Rating) and Cue Health (NASDAQ:HLTH – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.
Insider and Institutional Ownership
44.6% of Cue Health shares are held by institutional investors. 58.0% of Arrayit shares are held by insiders. Comparatively, 29.4% of Cue Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Get Arrayit alerts:Volatility & Risk
Arrayit has a beta of -0.48, meaning that its stock price is 148% less volatile than the S&P 500. Comparatively, Cue Health has a beta of 1.62, meaning that its stock price is 62% more volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and price targets for Arrayit and Cue Health, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Arrayit | 0 | 0 | 0 | 0 | N/A |
| Cue Health | 0 | 1 | 3 | 0 | 2.75 |
Cue Health has a consensus target price of $7.00, suggesting a potential upside of 248.26%.
Earnings and Valuation
This table compares Arrayit and Cue Health's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Arrayit | N/A | N/A | N/A | N/A | N/A |
| Cue Health | $522.06 million | 0.58 | $86.42 million | ($0.88) | -2.28 |
Cue Health has higher revenue and earnings than Arrayit.
Profitability
This table compares Arrayit and Cue Health's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Arrayit | N/A | N/A | N/A |
| Cue Health | -24.25% | -12.29% | -8.93% |
About Arrayit
(Get Rating)
Arrayit Corp. engages in developing, manufacturing and marketing life science tools and integrated systems for the analysis of genetic variation, biological function and diagnostics. Its products include microarrayers, Microarray Scanners, DNA Microarrays, Protein Microarrays, Microarray Printing, Microarray Substrate Slides, Microarray Instrument, Amplification & Labeling, purification kits, Microarray Tools, buffers and solutions, microarray Cleanrooms, Books & software, CGH Microarrays and Microarray Platforms. The company provides tools and services to genomic research centres, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Arrayit was founded by Todd J. Martinsky in November 1999 and is headquartered in Sunnyvale, CA.
About Cue Health
(Get Rating)
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Receive News & Ratings for Arrayit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arrayit and related companies with MarketBeat.com's FREE daily email newsletter.